PrisMN Phase 2 trial of budoprutug in Primary Membranous Nephropathy (pMN) initiated Phase 1 trial of budoprutug subcutaneous formulation ...
The veteran South American bank announced a share repurchase program. It will buy back up to roughly $157 million of its equity. Banco Macro announced the share repurchase program after U.S. market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback